Abcam PLC (NASDAQ:ABCZY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Monday.

According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “

Abcam PLC (ABCZY) traded down $0.41 during midday trading on Monday, reaching $13.40. 264 shares of the company traded hands, compared to its average volume of 649. Abcam PLC has a twelve month low of $9.13 and a twelve month high of $15.22.

TRADEMARK VIOLATION WARNING: This story was first reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/abcam-plc-abczy-stock-rating-lowered-by-zacks-investment-research/1701194.html.

Receive News & Ratings for Abcam PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.